CLOV vs INCY · rev $1.37B vs P/E 14, rev $4.24B
Clover Health Investments Corp (CLOV) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported INCY revenue for 2024-12-31 was $4.24B. Net income was $32.6M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
CLOV currently screens at market cap $1.55B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the CLOV and INCY stock pages for the full models.
Not investment advice.